National Center for Tumor Diseases (NCT) Heidelberg
Shady El-Husseiny, PhD, is a postdoctoral researcher at the National Center for Tumor Diseases (NCT) Heidelberg, specializing in the CRISPR base editing system to repair cancer mutations in patient-derived organoids. Previously, during a PhD at the DKFZ German Cancer Research Center, significant work included developing a CRISPR-based screen to identify novel cancer driver mutations and adapting base editing systems for therapeutic applications. Academic qualifications encompass a PhD in Oncology and Cancer Biology and an M.Sc. in Regenerative Biology and Medicine from Technische Universität Dresden, complemented by a Bachelor's degree in Pharmaceutical Sciences from Misr International University. Additional experience includes roles as a clinical research associate and various research positions, highlighting a robust background in cancer research and clinical trials.